Format

Send to

Choose Destination
J Consult Clin Psychol. 2015 Jun;83(3):637-42. doi: 10.1037/ccp0000021. Epub 2015 Apr 20.

Therapeutic alliance in a randomized clinical trial for bulimia nervosa.

Author information

1
Department of Psychiatry and Behavioral Neuroscience, The University of Chicago.
2
Department of Clinical Research, Neuropsychiatric Research Institute.
3
Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine.
4
Department of Psychiatry, University of Wisconsin.
5
Department of Psychiatry, University of Minnesota Medical School.

Abstract

OBJECTIVE:

This study examined the temporal relation between therapeutic alliance and outcome in two treatments for bulimia nervosa (BN).

METHOD:

Eighty adults with BN symptoms were randomized to 21 sessions of integrative cognitive-affective therapy (ICAT) or enhanced cognitive-behavioral therapy (CBT-E). Bulimic symptoms (i.e., frequency of binge eating and purging) were assessed at each session and posttreatment. Therapeutic alliance (Working Alliance Inventory) was assessed at Sessions 2, 8, 14, and posttreatment. Repeated-measures analyses using linear mixed models with random intercepts were conducted to determine differences in alliance growth by treatment and patient characteristics. Mixed-effects models examined the relation between alliance and symptom improvement.

RESULTS:

Overall, patients in both treatments reported strong therapeutic alliances. Regardless of treatment, greater therapeutic alliance between (but not within) subjects predicted greater reductions in bulimic behavior; reductions in bulimic behavior also predicted improved alliance. Patients with higher depression, anxiety, or emotion dysregulation had a stronger therapeutic alliance in CBT-E than ICAT, while those with more intimacy problems had greater improvement in therapeutic alliance in ICAT compared to CBT-E.

CONCLUSIONS:

Therapeutic alliance has a unique impact on outcome, independent of the impact of symptom improvement on alliance. Within- and between-subjects effects revealed that changes in alliance over time did not predict symptom improvement, but rather that individuals who had a stronger alliance overall had better bulimic symptom outcomes. These findings indicate that therapeutic alliance is an important predictor of outcome in the treatment of BN.

TRIAL REGISTRATION:

ClinicalTrials.gov NCT00773617.

PMID:
25894667
PMCID:
PMC4446165
DOI:
10.1037/ccp0000021
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for American Psychological Association Icon for PubMed Central
Loading ...
Support Center